TY - JOUR
T1 - Impact of renal function on the immediate and long-term outcomes of percutaneous recanalization of coronary chronic total occlusions
T2 - A systematic review and meta-analysis
AU - Moroni, Francesco
AU - Spangaro, Andrea
AU - Carlino, Mauro
AU - Baber, Usman
AU - Brilakis, Emmanouil S.
AU - Azzalini, Lorenzo
N1 - Funding Information:
Dr. Baber received honoraria from Boston Scientific, Amgen and Astra Zeneca; and institutional research grant from Astra Zeneca. Dr. Brilakis received consulting/speaker honoraria from Abbott Vascular, American Heart Association (associate editor Circulation), Biotronik, Boston Scientific, Cardiovascular Innovations Foundation (Board of Directors), CSI, Elsevier, GE Healthcare, InfraRedx, Medtronic, Siemens, and Teleflex ; research support from Regeneron and Siemens. Shareholder: MHI Ventures. Dr. Azzalini received honoraria from Abbott Vascular, Guerbet, Terumo, and Sahajanand Medical Technologies; and research support from ACIST Medical Systems , Guerbet, and Terumo. The other authors report no conflict of interest.
Funding Information:
Dr. Baber received honoraria from Boston Scientific, Amgen and Astra Zeneca; and institutional research grant from Astra Zeneca. Dr. Brilakis received consulting/speaker honoraria from Abbott Vascular, American Heart Association (associate editor Circulation), Biotronik, Boston Scientific, Cardiovascular Innovations Foundation (Board of Directors), CSI, Elsevier, GE Healthcare, InfraRedx, Medtronic, Siemens, and Teleflex; research support from Regeneron and Siemens. Shareholder: MHI Ventures. Dr. Azzalini received honoraria from Abbott Vascular, Guerbet, Terumo, and Sahajanand Medical Technologies; and research support from ACIST Medical Systems, Guerbet, and Terumo. The other authors report no conflict of interest.
Publisher Copyright:
© 2020 Elsevier B.V.
PY - 2020/10/15
Y1 - 2020/10/15
N2 - Background: Renal impairment is associated with worse in-hospital and long-term outcomes after coronary artery revascularization, yet limited evidence is available on its impact on short- and long-term outcomes after chronic total occlusion (CTO) percutaneous coronary intervention (PCI). Methods: We conducted a systematic review of the literature and subsequent random-effect meta-analysis according to the Preferred Reporting Items for Systematic Reviews and Meta Analyses (PRISMA) statement to evaluate the effect of chronic kidney disease (CKD), defined as estimated glomerular filtration rate < 60 ml/min/1.73 m2, on CTO PCI. The outcomes of this study were in-hospital death, procedural failure, contrast-induced acute kidney injury and all-cause death at follow-up. Results: Eight studies, with a total of 8439 patients (of whom 2256 had CKD) were included in the analysis. CKD was associated with higher technical (relative risk [RR] = 1.44, 95% confidence interval [CI] 1.14–1.82, p =.002) and procedural (risk ratio-RR = 1.40, 95% CI 1.00–1.96, p =.05) failure, higher in-hospital mortality (RR = 4.96, 95% CI 2.49–9.87 p <.001), bleeding complications (RR = 3.43, 95% CI 1.80–6.52, p <.001) and contrast-induced acute kidney injury (RR = 2.75, 95% CI 1.16–6.51, p =.001). CKD was also associated with higher all-cause mortality during long-term follow-up (RR = 3.56, 95% CI 1.08–5.99, p <.001). Conclusion: Compared with patients with normal renal function, CKD is associated with lower success and higher risk of acute and long-term complications after CTO PCI. Kidney function should be considered during decision-making on CTO recanalization.
AB - Background: Renal impairment is associated with worse in-hospital and long-term outcomes after coronary artery revascularization, yet limited evidence is available on its impact on short- and long-term outcomes after chronic total occlusion (CTO) percutaneous coronary intervention (PCI). Methods: We conducted a systematic review of the literature and subsequent random-effect meta-analysis according to the Preferred Reporting Items for Systematic Reviews and Meta Analyses (PRISMA) statement to evaluate the effect of chronic kidney disease (CKD), defined as estimated glomerular filtration rate < 60 ml/min/1.73 m2, on CTO PCI. The outcomes of this study were in-hospital death, procedural failure, contrast-induced acute kidney injury and all-cause death at follow-up. Results: Eight studies, with a total of 8439 patients (of whom 2256 had CKD) were included in the analysis. CKD was associated with higher technical (relative risk [RR] = 1.44, 95% confidence interval [CI] 1.14–1.82, p =.002) and procedural (risk ratio-RR = 1.40, 95% CI 1.00–1.96, p =.05) failure, higher in-hospital mortality (RR = 4.96, 95% CI 2.49–9.87 p <.001), bleeding complications (RR = 3.43, 95% CI 1.80–6.52, p <.001) and contrast-induced acute kidney injury (RR = 2.75, 95% CI 1.16–6.51, p =.001). CKD was also associated with higher all-cause mortality during long-term follow-up (RR = 3.56, 95% CI 1.08–5.99, p <.001). Conclusion: Compared with patients with normal renal function, CKD is associated with lower success and higher risk of acute and long-term complications after CTO PCI. Kidney function should be considered during decision-making on CTO recanalization.
KW - Chronic kidney disease
KW - Chronic total occlusion
KW - Complex PCI
KW - Contrast-induced acute kidney injury
KW - Percutaneous coronary intervention
UR - http://www.scopus.com/inward/record.url?scp=85086400930&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85086400930&partnerID=8YFLogxK
U2 - 10.1016/j.ijcard.2020.05.067
DO - 10.1016/j.ijcard.2020.05.067
M3 - Article
C2 - 32464250
AN - SCOPUS:85086400930
SN - 0167-5273
VL - 317
SP - 200
EP - 206
JO - International Journal of Cardiology
JF - International Journal of Cardiology
ER -